Avience Biomedicals IPO Reservation
The Avience Biomedicals IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 9,61,800 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
The Retail Individual Investor (RII) category has the highest allocation with 4,81,200 shares, representing 50.03% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 2,73,600 shares (28.45%), while Non-Institutional Investors (NIIs) receive 2,07,000 shares (21.52%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 1,38,000 shares (14.35%) and Small Non-Institutional Investors (SNII) with 69,000 shares (7.17%).
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 273600 | 28.45 | 0 |
| Non-Institutional | 207000 | 21.52 | 0 |
| BNII | 138000 | 14.35 | 0 |
| SNII | 69000 | 7.17 | 0 |
| Retail Investors | 481200 | 50.03 | 0 |
| Total | 961800 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Avience Biomedicals IPO?
The Retail Individual Investor (RII) quota in the Avience Biomedicals IPO comprises 4,81,200 equity shares, representing 50.03% of the total IPO issue.
What is the reservation for QIBs in the Avience Biomedicals IPO?
Qualified Institutional Buyers (QIBs) have been allocated 2,73,600 equity shares, representing 28.45% of the total IPO issue.
What is the reservation for HNI investors in the Avience Biomedicals IPO?
The Non-Institutional Investors (NII) category has been allotted 2,07,000 equity shares (21.52%). This category is further divided into: Big HNI (bNII): 69,000 shares (14.35%) Small HNI (sNII): 1,38,000 shares (7.17%).
What is the category-wise reservation in the Avience Biomedicals IPO?
The Avience Biomedicals IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 2,73,600 shares (28.45%). Non-Institutional Investors (NII): 2,07,000 shares (21.52%). Retail Individual Investors (RII): 4,81,200 shares (50.03%).
Is there a shareholder quota in the Avience Biomedicals IPO?
No. The Avience Biomedicals IPO does not include a shareholder reservation.